Results 151 to 160 of about 264,579 (254)

The influence of sleep factors and dietary habits on the disease pattern of ulcerative colitis patients with long and short disease courses – a multicentre cross-sectional analysis [PDF]

Mingyue Guo, Gechong Ruan, Xueli Ding, Yanbo Yu, Linglin Tian, Jun Shen, Xiaoyin Bai, Lingjuan Jiang, Weiyang Zheng, Huijun Shu, Xiaolan Zhang, Hong Yang   +11 more
openalex   +1 more source

Gallstone burden and risk in Korean patients with ulcerative colitis. [PDF]

Intest Res
Jeon SR.
europepmc   +1 more source

Three Janus kinase inhibitors in ulcerative colitis: is upadacitinib taking the lead? [PDF]

Intest Res
Jung YS.
europepmc   +1 more source

Randomised clinical study: discrepancies between patient‐reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis [PDF]

, 2015
Bindia Jharap, William J. Sandborn, Walter Reinisch, Geert D’Haens, A. M. Robinson, W. Wang, B Huang, A. Lazar, Roopal Thakkar, Jean‐Frédéric Colombel   +9 more
openalex   +1 more source

Macrophages: emerging targets for ulcerative colitis. [PDF]

Front Immunol
Chen S, Qin Z, Lin X, Zhou S, Xu Y, Zhu Y.   +5 more
europepmc   +1 more source

Could the discontinuous and structurally weaker colonic mucus gel in ulcerative colitis be a result of free radical damage?

, 1998
Jo Knight, JP Pearson, MT Droy-Lefaix, Adrian Allen   +3 more
openalex   +1 more source

Variability in Golimumab Exposure: A ‘Real-Life’ Observational Study in Active Ulcerative Colitis [PDF]

, 2016
Iris Detrez, Erwin Dreesen, Thomas Van Stappen, Annick de Vries, Els Brouwers, Gert Van Assche, Séverine Vermeire, Marc Ferrante, Ann Gils   +8 more
openalex   +1 more source

Salivary Biomarkers in Crohn's Disease and Ulcerative Colitis: A Scoping Review and Evidence Map. [PDF]

Int J Mol Sci
Santos KO, Sassaki LY, Brusco De Freitas M, Baima JP, Faria MH, Bizotto AL, Benício JP, Magalhães AC.   +7 more
europepmc   +1 more source

Remission in ulcerative colitis with standalone Ayurveda intervention: A Case Report. [PDF]

J Ayurveda Integr Med
Rastogi S, Sharma KG.
europepmc   +1 more source

Mirikizumab: a landmark in IL-23-targeted therapy for ulcerative colitis. [PDF]

Ann Med Surg (Lond)
Iqbal MU, Shafquat E, Khan MO, Abu Nahla U.   +3 more
europepmc   +1 more source